Home LiteratureArticle Details
PMID: 24596680 Published · epublish English Journal Article

Identifying Small Molecules which Inhibit Autophagy: a Phenotypic Screen Using Image-Based High-Content Cell Analysis.

Current chemical genomics and translational medicine ·Vol. 8 ·No. Suppl 1 ·2014-00-00 ·Pages 3-15

Peppard JV, Rugg C, Smicker M, Dureuil C, Ronan B, Flamand O, Durand L, Pasquier B

Abstract

Autophagy plays an important role in cancer and it has been suggested that it functions not only as a tumor suppressor pathway to prevent tumor initiation, but also as a pro-survival pathway that helps tumor cells endure metabolic stress and resist death triggered by chemotherapeutic agents, including acquired resistance. We aimed to identify small-molecule autophagy inhibitors using a HTS/HCA approach through a phenotypic, cell image-based assay, in order to screen multiple biological targets simultaneously and to screen compounds in a physiologically relevant environment. LC3 is a component of the autophagosome, which undergoes a cytoplasmic redistribution from diffuse to punctate dots during autophagy. We employed HeLa cells stably expressing EGFP-LC3 in a primary phenotypic screen. As a first step, a "Validation Library" of about 8,000 pre-selected compounds, about 25% of which had known biological activity and the others representing a range of chemical structures, was run in duplicate both to assess screening suitability and likely hit rate, and to give a valuable preview of possible active structures or biological targets. The primary screen of about 0.25 million compounds yielded around 10,500 positive compounds. These were tested in a suite of further cellular assays designed to eliminate unwanted positives, together with the application of chemi- and bioinformatics to pick out compounds with known biological activity. These processes enabled the selection of compounds that were the most promisingly active and specific. The screening "tree" identified, amongst others with as yet unidentified targets, chemical series active against autophagy-relevant biological targets ULK or Vsp34, validating the phenotypic screening methods selected. Finally, about 400 compounds were fully qualified after following this triage. The development of the assays, compound screening process and the compound triage is described.

Keywords
HTS LC3 autophagy high-content screening. image-based screening inhibitors phenotypic screening
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Peppard J V
Lead Generation and Candidate Realization, R&D, Bridgewater, NJ 07059, U.S.A.
Rugg C
Lead Generation and Candidate Realization, R&D, Bridgewater, NJ 07059, U.S.A.
Smicker M
Lead Generation and Candidate Realization, R&D, Bridgewater, NJ 07059, U.S.A.
Dureuil C
Oncology R&D, Sanofi, 94403, Vitry-Sur-Seine, France.
Ronan B
Oncology R&D, Sanofi, 94403, Vitry-Sur-Seine, France.
Flamand O
Oncology R&D, Sanofi, 94403, Vitry-Sur-Seine, France.
Durand L
Oncology R&D, Sanofi, 94403, Vitry-Sur-Seine, France.
Pasquier B
Oncology R&D, Sanofi, 94403, Vitry-Sur-Seine, France.
References (14)
14 references, click to expand
  1. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.
    J Biomol Screen. 1999;4(2):67-73 PMID: 10838414
  2. How were new medicines discovered?
    Nat Rev Drug Discov. 2011 Jun 24;10(7):507-19 PMID: 21701501
  3. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.
    Autophagy. 2008 Feb;4(2):151-75 PMID: 18188003
  4. Methods in mammalian autophagy research.
    Cell. 2010 Feb 5;140(3):313-26 PMID: 20144757
  5. How many drug targets are there?
    Nat Rev Drug Discov. 2006 Dec;5(12):993-6 PMID: 17139284
  6. Autophagy modulation as a potential therapeutic target for diverse diseases.
    Nat Rev Drug Discov. 2012 Sep;11(9):709-30 PMID: 22935804
  7. Autophagy in human health and disease.
    N Engl J Med. 2013 Feb 14;368(7):651-62 PMID: 23406030
  8. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase.
    Nat Cell Biol. 2013 Jul;15(7):741-50 PMID: 23685627
  9. Canonical and non-canonical autophagy: variations on a common theme of self-eating?
    Nat Rev Mol Cell Biol. 2011 Dec 14;13(1):7-12 PMID: 22166994
  10. The why and how of phenotypic small-molecule screens.
    Nat Chem Biol. 2013 Apr;9(4):206-9 PMID: 23508174
  11. Identifying mechanism-of-action targets for drugs and probes.
    Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11178-83 PMID: 22711801
  12. Open innovation for phenotypic drug discovery: The PD2 assay panel.
    J Biomol Screen. 2011 Jul;16(6):588-602 PMID: 21521801
  13. Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function.
    Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):2003-8 PMID: 22308354
  14. Gene silencing reveals a specific function of hVps34 phosphatidylinositol 3-kinase in late versus early endosomes.
    J Cell Sci. 2006 Apr 1;119(Pt 7):1219-32 PMID: 16522686
Article Info
Journal
Current chemical genomics and translational medicine
Abbr.
Curr Chem Genom Transl Med
ISSN
2213-9885
Published
2014-00-00
Epub
2014-00-07
Pages
3-15
Language
English
Region
United Arab Emirates
NLM ID
101616960
PMCID
PMC3941084
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com